DCTN2 and amyotrophic lateral sclerosis: Taken together, these findings suggest that ROPI's ameliorating effect on DCTN2 splicing abnormalities may improve ALS phenotypes by enhancing axonal transport functionality through the DCTN2‐Arp1 interaction.